Surfaxin is a lung surface acting agent, or "surfactant." It helps the lungs function normally.

Surfaxin is used to treat or prevent respiratory distress syndrome (RDS) in a premature baby whose lungs have not fully developed.

Surfaxin may also be used for purposes not listed in this medication guide.

Your baby will receive Surfaxin in a neonatal intensive care unit (NICU) or similar hospital setting.

Surfaxin is given directly into the baby's lungs through a breathing tube that is also connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Surfaxin is similar to the natural fluid in the lungs that helps maintain effective breathing.

Your baby will remain under constant supervision during treatment.

Before using Surfaxin

To best participate in the care of your baby while he or she is in the NICU, carefully follow all instructions provided by your baby's caregivers.

How is Surfaxin given?

Surfaxin is given directly into the baby's lungs through a breathing tube. Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.

The breathing tube is connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Surfaxin is given as soon as possible after the baby's birth, usually within 30 minutes.

Your baby's breathing, blood pressure, oxygen levels, and other vital signs will be watched closely during treatment with Surfaxin.

Surfaxin is given directly into the baby's lungs through a breathing tube. Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.

The breathing tube is connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Surfaxin is given as soon as possible after the baby's birth, usually within 30 minutes.

Your baby's breathing, blood pressure, oxygen levels, and other vital signs will be watched closely during treatment with Surfaxin.

To best participate in the care of your baby while he or she is in the NICU, carefully follow all instructions provided by your baby's caregivers.

Since Surfaxin is given as needed by a healthcare professional, it is not likely that your baby will miss a dose.

Since Surfaxin is given in a controlled medical setting by a healthcare professional, an overdose is not likely to occur. However, an overdose of Surfaxin is not expected to produce life-threatening symptoms.

Follow your doctor's instructions about any restrictions in feeding, medications, or activity after your baby has been treated with Surfaxin.

Surfaxin causes few side effects. There is a possibility that the baby will have breathing difficulties during treatment, and these problems may require further treatment by health care professionals. Your baby will remain under constant supervision during treatment with Surfaxin.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.